"Bio"-macromolecules: polymer-protein conjugates as emerging scaffolds for therapeutics

Dorothee E. Borchmann, Tom P. Carberry, Marcus Weck

Research output: Contribution to journalArticle

Abstract

Polymer-protein conjugates are biohybrid macromolecules derived from covalently connecting synthetic polymers with polypeptides. The resulting materials combine the properties of both worlds: chemists can engineer polymers to stabilize proteins, to add functionality, or to enhance activity; whereas biochemists can exploit the specificity and complexity that Nature has bestowed upon its macromolecules. This has led to a wealth of applications, particularly within the realm of biomedicine. Polymer-protein conjugation has expanded to include scaffolds for drug delivery, tissue engineering, and microbial inhibitors. This feature article reflects upon recent developments in the field and discusses the applications of these hybrids from a biomaterials standpoint.

Original languageEnglish (US)
Pages (from-to)27-43
Number of pages17
JournalMacromolecular Rapid Communications
Volume35
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Scaffolds (biology)
Macromolecules
Scaffolds
Polymers
Proteins
Polypeptides
Biocompatible Materials
Drug delivery
Tissue engineering
Biomaterials
Engineers
Peptides

Keywords

  • bioengineering
  • biological applications of polymers
  • biomaterials
  • poly(ethylene glycol)
  • proteins

ASJC Scopus subject areas

  • Organic Chemistry
  • Materials Chemistry
  • Polymers and Plastics

Cite this

"Bio"-macromolecules : polymer-protein conjugates as emerging scaffolds for therapeutics. / Borchmann, Dorothee E.; Carberry, Tom P.; Weck, Marcus.

In: Macromolecular Rapid Communications, Vol. 35, No. 1, 01.2014, p. 27-43.

Research output: Contribution to journalArticle

@article{9ddcbcba511f4128a9e1a2952854871e,
title = "{"}Bio{"}-macromolecules: polymer-protein conjugates as emerging scaffolds for therapeutics",
abstract = "Polymer-protein conjugates are biohybrid macromolecules derived from covalently connecting synthetic polymers with polypeptides. The resulting materials combine the properties of both worlds: chemists can engineer polymers to stabilize proteins, to add functionality, or to enhance activity; whereas biochemists can exploit the specificity and complexity that Nature has bestowed upon its macromolecules. This has led to a wealth of applications, particularly within the realm of biomedicine. Polymer-protein conjugation has expanded to include scaffolds for drug delivery, tissue engineering, and microbial inhibitors. This feature article reflects upon recent developments in the field and discusses the applications of these hybrids from a biomaterials standpoint.",
keywords = "bioengineering, biological applications of polymers, biomaterials, poly(ethylene glycol), proteins",
author = "Borchmann, {Dorothee E.} and Carberry, {Tom P.} and Marcus Weck",
year = "2014",
month = "1",
doi = "10.1002/marc.201300792",
language = "English (US)",
volume = "35",
pages = "27--43",
journal = "Macromolecular Rapid Communications",
issn = "1022-1336",
publisher = "Wiley-VCH Verlag",
number = "1",

}

TY - JOUR

T1 - "Bio"-macromolecules

T2 - polymer-protein conjugates as emerging scaffolds for therapeutics

AU - Borchmann, Dorothee E.

AU - Carberry, Tom P.

AU - Weck, Marcus

PY - 2014/1

Y1 - 2014/1

N2 - Polymer-protein conjugates are biohybrid macromolecules derived from covalently connecting synthetic polymers with polypeptides. The resulting materials combine the properties of both worlds: chemists can engineer polymers to stabilize proteins, to add functionality, or to enhance activity; whereas biochemists can exploit the specificity and complexity that Nature has bestowed upon its macromolecules. This has led to a wealth of applications, particularly within the realm of biomedicine. Polymer-protein conjugation has expanded to include scaffolds for drug delivery, tissue engineering, and microbial inhibitors. This feature article reflects upon recent developments in the field and discusses the applications of these hybrids from a biomaterials standpoint.

AB - Polymer-protein conjugates are biohybrid macromolecules derived from covalently connecting synthetic polymers with polypeptides. The resulting materials combine the properties of both worlds: chemists can engineer polymers to stabilize proteins, to add functionality, or to enhance activity; whereas biochemists can exploit the specificity and complexity that Nature has bestowed upon its macromolecules. This has led to a wealth of applications, particularly within the realm of biomedicine. Polymer-protein conjugation has expanded to include scaffolds for drug delivery, tissue engineering, and microbial inhibitors. This feature article reflects upon recent developments in the field and discusses the applications of these hybrids from a biomaterials standpoint.

KW - bioengineering

KW - biological applications of polymers

KW - biomaterials

KW - poly(ethylene glycol)

KW - proteins

UR - http://www.scopus.com/inward/record.url?scp=84891625953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891625953&partnerID=8YFLogxK

U2 - 10.1002/marc.201300792

DO - 10.1002/marc.201300792

M3 - Article

C2 - 24323623

AN - SCOPUS:84891625953

VL - 35

SP - 27

EP - 43

JO - Macromolecular Rapid Communications

JF - Macromolecular Rapid Communications

SN - 1022-1336

IS - 1

ER -